IP Library Granted Patent US 7,645,268
Granted Patent B2
US 7,645,268 · App. 10/808,357 · Granted Jan 12, 2010

Needles and methods of using same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,645,268
App. No.
10/808,357
Granted
Jan 12, 2010
Kind
B2
Abstract

A needle having a shaft with a distal end defining a distal opening. The shaft has a longitudinal axis that extends through the distal opening and the distal opening has a projected area that is smaller than a cross-sectional area of a section of the shaft proximal to the distal end of the shaft. Also provided are methods of directly delivering a therapeutic agent to a target site using a Huber needle or pencil-point needle.

Claims (56)

1. A drug delivery device comprising:

a catheter or syringe having a distal portion, and

a needle attached to the distal portion, the needle comprising during use:

a shaft having a distal end defining a distal opening and having a longitudinal axis extending through the distal opening,

the distal opening having a projected area that is smaller than a cross-sectional area of the opening of the shaft proximal to the distal end of the shaft,

the distal end comprising opposing first and second surfaces, wherein the first surface is indented towards the second surface to form a concavity on an outer portion of the first surface, and wherein the first surface blocks a majority of the distal opening.

2. The needle of claim 1 , wherein the distal end of the shaft comprises at least one port on a side surface thereof.

3. The needle of claim 1 , wherein the distal end of the shaft is tapered.

4. The needle of claim 1 , wherein the distalmost end is a curvilinear blunt tip.

5. A method of delivering a therapeutic agent to a target site of a body comprising:

providing a drug delivery device comprising:

a non-coring needle having a distal end defining a distal opening and having a longitudinal axis extending through the distal opening,

the distal end comprising a first surface indented towards a second surface to form a concavity on an outer portion of the first surface, wherein the first surface blocks a majority of the distal opening,

the distal opening having a projected area that is smaller than a cross-sectional area of the opening of the shaft proximal to the distal end of the shaft,

puncturing a body tissue with the non-coring needle tip; and

delivering the therapeutic agent through the non-coring needle to a target site of a body.

6. The method of claim 5 , wherein delivering the therapeutic agent comprises directly delivering the therapeutic agent to the target site.

7. The method of claim 6 , wherein the target site is the heart.

8. The method of claim 6 , wherein the target site is the myocardium.

9. The method of claim 5 , wherein the target site is selected from a group consisting of the heart, lung, brain, liver, skeletal muscle, smooth muscle, kidney, bladder, intestines, stomach, pancreas, ovary, prostate and cartilage.

10. The method of claim 5 , wherein the target site is a spinal column.

11. A method of accessing a drug delivery port comprising:

providing a drug delivery device comprising:

a non-coring needle having a distal end defining a distal opening and having a longitudinal axis extending through the distal opening,

the distal end comprising a first surface indented towards a second surface to form a concavity on an outer portion of the first surface, wherein the first surface blocks a majority of the distal opening,

the distal opening having a projected area that is smaller than a cross-sectional area of the opening of the shaft proximal to the distal end of the shaft; and

inserting the needle of the drug delivery device into a drug delivery port to access the drug delivery port.

12. The method of claim 11 , wherein accessing the drug delivery port comprises introducing a therapeutic agent through the needle into the drug delivery port.

13. The method of claim 11 , wherein the drug delivery port comprises a septum, the needle of the drug delivery device piercing the septum to access the drug delivery port.

14. A method of collecting a fluid sample from a body comprising:

providing a drug delivery device comprising:

a non-coring needle having a distal end defining a distal opening and having a longitudinal axis extending through the distal opening,

the distal end comprising a first surface indented towards a second surface to form a concavity on an outer portion of the first surface, wherein the first surface blocks a majority of the distal opening,

the distal opening having a projected area that is smaller than a cross-sectional area of the opening of the shaft proximal to the distal end of the shaft;

puncturing a body tissue with the non-coring needle;

inserting the needle into a fluid containment site of a body; and

creating a vacuum in the drug delivery device to collect a fluid sample from the fluid containment site of the body.

15. The method of claim 14 , wherein the fluid sample comprises blood, amniotic fluid, serous fluid, or cerebrospinal fluid.

16. A drug delivery device comprising:

a catheter or syringe having a distal portion, and

a needle attached to the distal portion, the needle comprising during use:

a shaft having a distal end comprising a first surface indented towards a second surface to form a concavity and to define a distal opening having a U-shape when viewed along the longitudinal axis from the front of the distal end,

the shaft having a longitudinal axis extending through the distal opening,

the distal opening having a projected area that is smaller than a cross-sectional area of a section of the shaft proximal to the distal end of the shaft.

17. The needle of claim 16 , wherein the second surface is parallel to the longitudinal axis of the shaft.

18. The needle of claim 16 , wherein the distalmost end is a curvilinear blunt tip.

19. The needle of claim 16 , wherein the distal end of the shaft comprises at least one port on a side surface thereof.

20. A drug delivery device comprising:

a catheter or syringe having a distal portion, and

a needle attached to the distal portion, the needle comprising during use:

a shaft having a distal end comprising a first surface indented towards a second surface to form a concavity and to define a distal opening, said distal opening being discontinuous and having a substantial U-shape when viewed along the longitudinal axis from the front of the distal end, wherein a bottom of the U-shape is closed,

the shaft having a longitudinal axis extending through the distal opening,

the distal opening having a projected area that is smaller than a cross-sectional area of a section of the shaft proximal to the distal end of the shaft.

21. The needle of claim 20 , wherein the distalmost end is a curvilinear blunt tip.

22. The needle of claim 20 , wherein the distal end of the shaft comprises at least one port on a side surface thereof.

23. The needle of claim 20 , wherein the center of the concavity of the first surface is in contact with the second surface.

Assignments (2)
CHANGE OF NAME Recorded Nov 6, 2006
From: SCIMED LIFE SYSTEMS, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 018505/0868 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2004
From: MICKLEY, TIMOTHY J.; USCHOLD, JOHN E.
To: SCIMED LIFE SYSTEMS
Reel/Frame 015154/0387 →